Login
$LXRX
$1.49 +$0.01 (0.34%) Close

Insider Transactions

What Lexicon Pharmaceuticals, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

3 months 12 months
Open-market buys 0 8
Sells 0 0
Total trades 0 45

Shares traded

3 months 12 months
Acquired 0 47,298,970
Disposed 0 676,672
Net activity +0 +46,622,298

Common stock only — 2 reported trades in the last 12 months are in a security these totals do not cover.

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

Insider Relation Date Transaction Shares Price Value Shares held
Debbane Raymond Director Jun 03 Exercise / conversion · M +89,312 — — 1,995,498
Amouyal Philippe Director Jun 03 Exercise / conversion · M +89,312 — — 374,486
Barker Sam L Director Jun 03 Exercise / conversion · M +89,312 — — 213,771
Sobecki Christopher J Director Jun 03 Exercise / conversion · M +89,312 — — 293,177
Cheung Ivan Director Jun 03 Exercise / conversion · M +89,312 — — 89,312
Sullivan Diane E. Director Jun 03 Exercise / conversion · M +89,312 — — 126,122
Swain Judith L Director Jun 03 Exercise / conversion · M +89,312 — — 174,486
Artal Participations S.a r.l. Director Apr 30 Exercise / conversion · M +20,421,735 — — 175,156,062
Gopinathan Suma SVP, Discovery Feb 28 Withheld — tax / exercise cost · F −24,338 $1.47 −$35.8K 150,132
Gopinathan Suma SVP, Discovery Feb 28 Exercise / conversion · M +65,640 — — 174,470
Gopinathan Suma SVP, Discovery Feb 28 Exercise / conversion · M +20,310 — — 108,830
Gopinathan Suma SVP, Discovery Feb 28 Exercise / conversion · M +14,000 — — 88,520
DeFrancesco Lisa SVP, IR and Corp Comm Feb 28 Withheld — tax / exercise cost · F −74,572 $1.47 −$110K 93,869
DeFrancesco Lisa SVP, IR and Corp Comm Feb 28 Exercise / conversion · M +128,190 — — 168,441
DeFrancesco Lisa SVP, IR and Corp Comm Feb 28 Exercise / conversion · M +24,674 — — 40,251
Granowitz Craig B SVP, Chief Medical Officer Feb 28 Withheld — tax / exercise cost · F −109,098 $1.47 −$160K 323,430
Granowitz Craig B SVP, Chief Medical Officer Feb 28 Exercise / conversion · M +202,260 — — 432,528
Granowitz Craig B SVP, Chief Medical Officer Feb 28 Exercise / conversion · M +74,226 — — 230,268
Granowitz Craig B SVP, Chief Medical Officer Feb 28 Exercise / conversion · M +35,790 — — 156,042
Coiante Scott M SVP, Chief Financial Officer Feb 28 Withheld — tax / exercise cost · F −54,881 $1.47 −$80.7K 105,356

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support